Literature DB >> 1371670

Cellular mechanism of the insulin-like effect of growth hormone in adipocytes. Rapid translocation of the HepG2-type and adipocyte/muscle glucose transporters.

J W Tanner1, K A Leingang, M M Mueckler, K C Glenn.   

Abstract

The cellular mechanism whereby growth hormone (GH) acutely stimulates adipocyte glucose uptake was studied in cultures of primary rat adipocytes differentiated in vitro. Preadipocytes were isolated by collagenase digestion of inguinal fat-pads from young rats and were differentiated in the presence of 3-isobutyl-1-methylxanthine, insulin and dexamethasone. The development of an adipocyte morphology (i.e. lipid inclusions) was observed over 6 days after initiation of differentiation. Coincident with this phenotypic change was an increase in glyceraldehyde-3-phosphate dehydrogenase (GPDH) activity and in cellular content of the HepG2-type (Glut1) and adipocyte/muscle (Glut4) glucose transporter isoforms as determined by Western immunoblotting of total cellular protein. Age-matched undifferentiated cells expressed the Glut1 transporter and low levels of GPDH, but neither accumulated lipid nor exhibited measurable expression of the Glut4 protein. On day 6 after the initiation of differentiation, GH and insulin stimulated 2-deoxy[14C]glucose uptake in a dose- and time-dependent fashion in adipocytes cultured under serum-free conditions for at least 15 h. Western-blot analysis of subcellular fractions revealed that both GH and insulin rapidly (within 20 min) stimulated translocation of the Glut1 and Glut4 proteins from a low-density microsomal fraction to the plasma membrane. Confirmatory evidence was provided in immunocytochemical experiments utilizing antisera directed against the C-terminal region of the Glut4 protein and a fluorescein isothiocyanate-labelled second antibody. Observation of the cells via confocal laser microscopic imaging was consistent with glucose transporter redistribution from an intracellular region to the plasma membrane after treatment with GH or insulin. On the basis of these data, we suggest that the insulin-like effect of GH on adipocyte glucose transport involves translocation of the Glut1 and Glut4 proteins to the plasma membrane. Furthermore, stimulation of glucose-transporter translocation by both GH and insulin may indicate a common cell signalling element between the adipocyte GH and insulin receptors or, alternatively, the existence of multiple cellular mechanisms for stimulating glucose-transporter translocation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371670      PMCID: PMC1130895          DOI: 10.1042/bj2820099

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  Growth hormone receptor and serum binding protein: purification, cloning and expression.

Authors:  D W Leung; S A Spencer; G Cachianes; R G Hammonds; C Collins; W J Henzel; R Barnard; M J Waters; W I Wood
Journal:  Nature       Date:  1987 Dec 10-16       Impact factor: 49.962

2.  Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein.

Authors:  H Fukumoto; S Seino; H Imura; Y Seino; R L Eddy; Y Fukushima; M G Byers; T B Shows; G I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

3.  Multiple effects of growth hormone on lipolysis.

Authors:  H M Goodman
Journal:  Endocrinology       Date:  1968-08       Impact factor: 4.736

4.  Regulation of insulin-like growth factor messenger ribonucleic acid in rat growth plate by growth hormone.

Authors:  J Isgaard; C Möller; O G Isaksson; A Nilsson; L S Mathews; G Norstedt
Journal:  Endocrinology       Date:  1988-04       Impact factor: 4.736

Review 5.  The nature and regulation of the insulin receptor: structure and function.

Authors:  M P Czech
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

6.  Rapid and transitory stimulation of 3-O-methylglucose transport by growth hormone.

Authors:  C Carter-Su; F W Rozsa; X Wang; J R Stubbart
Journal:  Am J Physiol       Date:  1988-11

7.  Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein.

Authors:  D E James; R Brown; J Navarro; P F Pilch
Journal:  Nature       Date:  1988-05-12       Impact factor: 49.962

8.  Growth hormone induction of insulin-like growth factor I messenger RNA in primary cultures of rat liver cells.

Authors:  G Norstedt; C Möller
Journal:  J Endocrinol       Date:  1987-10       Impact factor: 4.286

9.  Regulation of insulin-like growth factor I gene expression by growth hormone.

Authors:  L S Mathews; G Norstedt; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site.

Authors:  K Suzuki; T Kono
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more
  5 in total

Review 1.  Molecular heterogeneity of human GH: from basic research to clinical implications.

Authors:  C L Boguszewski
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

2.  Human adipose tissue is a source of multipotent stem cells.

Authors:  Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

3.  Functional growth hormone (GH) receptors and GH are expressed by preimplantation mouse embryos: a role for GH in early embryogenesis?

Authors:  M Pantaleon; E J Whiteside; M B Harvey; R T Barnard; M J Waters; P L Kaye
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Increased hepatic delta 6-desaturase activity with growth hormone expression in the MG101 transgenic mouse.

Authors:  M T Nakamura; S D Phinney; A B Tang; A M Oberbauer; J B German; J D Murray
Journal:  Lipids       Date:  1996-02       Impact factor: 1.880

5.  Experimental hyperlipidemia dramatically reduces access of insulin to canine skeletal muscle.

Authors:  Jenny D Chiu; Cathryn M Kolka; Joyce M Richey; Lisa N Harrison; Edward Zuniga; Erlinda L Kirkman; Richard N Bergman
Journal:  Obesity (Silver Spring)       Date:  2009-06-11       Impact factor: 5.002

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.